Evaluation of atovaquone in the treatment of patients with uncomplicated Plasmodium falciparum malaria

1995/01/01 by P L Chiodini, P. L. Chiodini, Christopher P. Conlon +11
Medicine · #Malaria Research and Control #Mosquito-borne diseases and control

paper · doi:10.1093/jac/36.6.1073

openalex publication_date 1995/01/01 · openalex created_date 2016/06/24 · openalex updated_date 2026/07/29

Abstract

The activity of atovaquone in patients with oligosymptomatic Plasmodium falciparum malaria was assessed in an open, non-comparative clinical study. The patients showed a good clinical response, but there was a high rate of recrudescence. The activity of atovaquone in combination with another antimalarial agent should be investigated.

Related

• Complete attenuation of Plasmodium falciparum sporozoites by atovaquone–proguanil
• Increasing day three parasitaemia is observed after treatment of patients with artemether-lumefantrine and single dose of primaquine for uncomplicated Plasmodium falciparum malaria in Arbaminch Zuria district, Southwest Ethiopia
• In vivo antimalarial activity of yoyo bitters®, a polyherbal formulation against Plasmodium berghei in Swiss mice
• Radical cure of experimental babesiosis in immunodeficient mice using a combination of an endochin-like quinolone and atovaquone
• Therapeutic efficacy and safety of artesunate + amodiaquine and artemether + lumefantrine in treating uncomplicated Plasmodium falciparum malaria in children on the rainy south-east coast of Madagascar